In addition, acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) are other critical enzymes in health care, and their inhibitors are used in the clinical management of Alzheimer’s disease. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.